MAYLA CHUNG: Open Payments
NPI 1699386797 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,304 in 55 payments from 20 companies in 2025. Trend: 2023 $98 · 2024 $237 · 2025 $1,304
Food & beverage: $1,205Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $198 |
| Aimmune Therapeutics, Inc. | 6 | $149 |
| ABBVIE INC. | 7 | $129 |
| PFIZER INC. | 6 | $117 |
| Madrigal Pharmaceuticals | 5 | $107 |
| Gilead Sciences, Inc. | 5 | $95 |
| Regeneron Healthcare Solutions, Inc. | 4 | $77 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $68 |
| GENZYME CORPORATION | 3 | $62 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $46 |
Products named: TREMFYA, ZENPEP, DUPIXENT, REZDIFFRA, VELSIPITY, RINVOQ, EOHILIA, XIFAXAN.
Industry payments across NC — which companies pay providers there.
